Buscar | Bundas24

Ksh Dbmr agregó una foto Networking
2025-09-10 09:05:48 -

Hypercholesterolemia Drugs Market Expands with Statins, PCSK9 Inhibitors, and Preventive Healthcare Trends
Executive Summary Hypercholesterolemia Drugs Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses a growth rate in the hypercholesterolemia drugs market in the forecast period 2023-2030. The expected CAGR of hypercholesterolemia drugs market tends to be around 16.00% in the mentioned forecast period. The market was valued at USD 13 billion in 2022...

0 Commentarios 0 Acciones 186 Views 0 Vista previa

Please log in to like, share and comment!
Kajalpatil Patil agregó una foto Health
2025-05-22 08:51:56 -

PCSK9 Inhibitors Market Driven by Cardiovascular Disease Prevalence
PCSK9 inhibitors are a class of lipid-lowering biologics designed to target proprotein convertase subtilisin/kexin type 9, offering a potent reduction in low-density lipoprotein (LDL) cholesterol for patients at high cardiovascular risk. Administered via subcutaneous injection, these monoclonal antibodies and small molecules block PCSK9 interaction with LDL receptors, enhancing receptor...

0 Commentarios 0 Acciones 797 Views 0 Vista previa

Please log in to like, share and comment!
Kislay Kumar agregó una foto Health
2025-06-02 13:26:56 -

Homozygous Familial Hypercholesterolemia Market is driven by innovative lipid-lowering therapies
Homozygous familial hypercholesterolemia (HoFH) is an inherited disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, leading to early onset atherosclerosis and cardiovascular complications. The HoFH market comprises specialized therapeutics such as PCSK9 inhibitors, microsomal triglyceride transfer protein (MTP) inhibitors, antisense...

0 Commentarios 0 Acciones 749 Views 0 Vista previa

Please log in to like, share and comment!